Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Acta Oncol ; 56(2): 278-287, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-28068157

RESUMO

BACKGROUND: The best practice for the organization of follow-up care in oncology is under debate, due to growing numbers of cancer survivors. Understanding survivors' preferences for follow-up care is elementary for designing patient-centred care. Based on data from prostate cancer and melanoma survivors, this study aims to identify: 1) preferences for follow-up care providers, for instance the medical specialist, the oncology nurse or the general practitioner; 2) characteristics associated with these preferences and 3) the preferred care provider to discuss cancer-related problems. MATERIAL AND METHODS: Survivors diagnosed with prostate cancer (N = 535) and melanoma (N = 232) between 2007 and 2013 as registered in The Netherlands Cancer Registry returned a questionnaire (response rate was 71% and 69%, respectively). A latent class cluster model analysis was used to define preferences and a multinomial logistic regression analysis was used to identify survivor-related characteristics associated with these preferences. RESULTS: Of all survivors, 29% reported no preference, 40% reported a preference for the medical specialist, 20% reported a preference for both the medical specialist and the general practitioner and 11% reported a preference for both the medical specialist and the oncology nurse. Survivors who were older, lower/intermediate educated and women were more likely to have a preference for the medical specialist. Lower educated survivors were less likely to have a preference for both the medical specialist and the general practitioner. Overall, survivors prefer to discuss diet, physical fitness and fatigue with the general practitioner, and hereditary and recurrence with the medical specialist. Only a small minority favored to discuss cancer-related problems with the oncology nurse. CONCLUSION: Survivors reported different preferences for follow-up care providers based on age, education level, gender and satisfaction with the general practitioner, showing a need for tailored follow-up care in oncology. The results indicate an urgency to educate patients about transitions in follow-up care.


Assuntos
Assistência ao Convalescente , Melanoma/mortalidade , Neoplasias da Próstata/mortalidade , Sobreviventes , Idoso , Estudos Transversais , Feminino , Pessoal de Saúde , Humanos , Masculino , Melanoma/terapia , Pessoa de Meia-Idade , Educação de Pacientes como Assunto , Preferência do Paciente , Neoplasias da Próstata/terapia , Sistema de Registros
2.
Ned Tijdschr Geneeskd ; 153: B358, 2009.
Artigo em Holandês | MEDLINE | ID: mdl-19785805

RESUMO

A 58-year-old man presented with a necrotizing ulcus on his back due to a complicated fluoroscopy-guided intervention procedure a few months before with a high total radiation dose.


Assuntos
Fluoroscopia/efeitos adversos , Doses de Radiação , Úlcera/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Úlcera/patologia
3.
J Dtsch Dermatol Ges ; 7(3): 237-8, 2009 Mar.
Artigo em Inglês, Alemão | MEDLINE | ID: mdl-19054423

RESUMO

Local anesthetics are widely used drugs. In contrast to the local anesthetics of the ester group, the ones of the amide group (for example prilocaine and lidocaine) are considered to be rare sensitizers. Positive patch test results to both prilocaine and lidocaine in EMLA cream might indicate potential cross-reactivity.


Assuntos
Dermatite Alérgica de Contato/diagnóstico , Dermatite Alérgica de Contato/etiologia , Toxidermias/diagnóstico , Toxidermias/etiologia , Lidocaína/efeitos adversos , Prilocaína/efeitos adversos , Idoso de 80 Anos ou mais , Anestésicos Locais/efeitos adversos , Dermatite Alérgica de Contato/terapia , Toxidermias/terapia , Feminino , Humanos , Combinação Lidocaína e Prilocaína , Pomadas/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...